what percent of donations to memorial sloan kettering cancer center is used for patients
Acme-Rated Charity
Programme Pct
Amount spent on programs
relative to overhead.
Cost to Heighten $100
Corporeality spent to enhance
$100 of contributions.
Contact Information
Memorial Sloan Kettering Cancer Center
1275 York Artery
New York, NY 10065
Stated Mission
Leadership in the prevention, treatment, and cure of cancer through excellence, vision, and toll-effectiveness in patient care, outreach programs, research, and education.
Ratings & Metrics
Data based on Fiscal Twelvemonth Ended 12/31/2019
Program Percentage: 98%
The percentage of Memorial Sloan Kettering Cancer Center's cash budget information technology spends on programs relative to overhead (fundraising, direction, and general expenses).
$5,244,000,000
Calculated Total Expenses
(rounded)
Cost to Raise $100: $31
How many dollars Memorial Sloan Kettering Cancer Centre spends on fundraising to raise each $100 of contributions.
$263,000,000
Calculated Total Contributions
(rounded)
Joint Costs
Memorial Sloan Kettering Cancer Middle's rating was adapted for Joint Costs. If y'all are a donor who considers direct mail, telemarketing, and other Joint Cost solicitations to exist true charitable programs, the below efficiency ratios, which were not adjusted for articulation costs, may better reflect your goals.
| Program % | Cost to Heighten $100 |
|---|---|
| 98% | $29 |
Bookkeeping rules let charities to report some telemarketing, directly mail, and other solicitation costs as Program expenses. CharityWatch believes that nearly donors practise not consider a clemency'southward solicitation activities to be the Programs they are intending to back up with their donations. We therefore conform such expenses out of a charity'southward reported Program expense and add it to Fundraising expense prior to calculating its rating.
Regime Funding
0% to 24%
Percent of cash acquirement
coming from regime sources
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| Memorial Sloan Kettering Cancer Center & Affiliated Corporations | Combined Audited Financial Statements | Multiple |
| Memorial Sloan Kettering Cancer Eye | IRS Form 990 | 91-2154267 |
| Entity: Memorial Sloan Kettering Cancer Middle & Affiliated Corporations Certificate Type: Combined Audited Financial Statements Tax ID: Multiple |
| Entity: Memorial Sloan Kettering Cancer Middle Document Type: IRS Grade 990 Tax ID: 91-2154267 |
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may desire to consider a charity's willingness to be open and transparent with CharityWatch to exist a good litmus test for determining its commitment to public accountability.
Memorial Sloan Kettering Cancer Center
meets governance benchmarks.
Memorial Sloan Kettering Cancer Center
meets transparency benchmarks.
| Transparency | |
|---|---|
| Provides Financial Information | |
| Audit Accessibility | |
| Governance: Policies | |
|---|---|
| Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Involvement Policy | |
| Reports required, annual disclosure past officers, directors, and key staff of interests that could requite rise to conflicts | |
| Reports having a written Whistleblower Policy | |
| Reports having a written Document Retention and Devastation Policy | |
| Governance: Financials | |
|---|---|
| Reports providing re-create of tax class to all board members prior to filing it with IRS | |
| Reports that financial statements were audited by an contained auditor | |
| Governance: Board of Directors | |
|---|---|
| Reports at least 5 voting board members | |
| 51% or more of voting board members reported as independent | |
| Reports documenting minutes of board and board committee meetings | |
| Privacy Policy | |
|---|---|
| Privacy Policy | Opt-Out Policy |
Top Salaries
| Proper name | Title | Bounty | ||
|---|---|---|---|---|
| 1 | Craig B. Thompson, Yard.D. | President/CEO | $5,734,609 | |
| Note: Includes $3,330,000 bonus & incentive compensation. | ||||
| ii | Kathryn Martin | COO | $two,625,946 | |
| 3 | David Jones, Grand.D. | Chief Attention - Department of Surgery | $2,591,447 | |
| 1 Name: Craig B. Thompson, M.D. Title: President/CEO Compensation: $5,734,609 |
| Note: Includes $iii,330,000 bonus & incentive compensation. |
| 2 Proper name: Kathryn Martin Title: COO Bounty: $2,625,946 |
| iii Proper noun: David Jones, M.D. Championship: Chief Attending - Department of Surgery Compensation: $2,591,447 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS revenue enhancement filings, and often review other documents such as state filings, almanac reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of involvement to donors.
| CharityWatch'south rating of Memorial Sloan Kettering Cancer Center includes the financial activities of the legal entities included in its combined audited financial statements for the fiscal year-concluded 12/31/2019. This includes the public clemency, Memorial Sloan Kettering Cancer Center, as well as the post-obit public charity incorporated affiliates: Memorial Hospital for Cancer and Allied Diseases (the Hospital); Sloan Kettering Institute for Cancer Research (the Institute); S.K.I. Realty, Inc.; MSK Insurance United states, Inc. (MSKI); the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences; Prostate Cancer Clinical Trials Consortium, LLC; Ralph Lauren Center for Cancer Care and Prevention; and MSK Proton, Inc. |
| According to the Memorial Sloan Kettering Cancer Center (the Found) combined inspect of December 31, 2019 (Note xv, Subsequent Events): "Due to the global viral outbreak caused by Coronavirus Illness 2019 (COVID-19) in 2020, there take been resulting effects which could negatively bear on the Establishment'south financial status, including significant stock market exchange volatility, various temporary business closures and event cancellations, and other effects which could result in supply disruptions and/or decisions to defer elective procedures and other medical treatments at the Institution as the broader economic impact of COVID-nineteen develops. The ultimate impact of these matters to the Institution and its financial status is presently unknown..." |
| According to the Memorial Sloan Kettering Cancer Center (the Institute or the Heart) 2019 tax filing, the Heart reports re: Business Transactions Involving Interested Persons (IRS Class 990, Schedule L, Parts IV & V): "1. Dr. Craig Thompson is the President of the Institute. His spouse is a laboratory member for Sloan-Kettering Institute for Cancer Enquiry. Her compensation for 2019 was $288,843." "two. Mr. Michael P. Gutnick is the Executive Vice President and Chief Fiscal Officer until his retirement in September 2019. His son is a fund coordinator in the Division of Medicine in the Hospital. His son's total compensation for 2019 was $153,341." "3. Ms. Jamie Nicholls is a board fellow member of the Institution. Her spouse is a co-founder of King Street Majuscule Management. During 2019, the Centre paid Male monarch Street $473,747 in management fees. During 2019, carried involvement was $176,742. MSK gave a redemption observe at the stop of 2018, and pursuant to the standard redemption terms, maintained a small and declining exposure to King Street throughout 2019 and into 2020. The Institution invested in King Street prior to Ms. Nicholls joining the board of Memorial Sloan Kettering Cancer Center." "iv. Lisa DeAngelis M.D. is the Physician-in-Chief and Chief Medical Officer of the system. She is 100% owner of Memorial Medical Care PC (MMPC). MMPC is a section 501(c)(3) revenue enhancement-exempt captive medical group. MMPC provides dwelling house health care to the Hospital's bone marrow transplant patients. The PC and the Hospital have a management understanding where there is no net cost to the Hospital for the service. The Hospital provides and charges the PC for the services rendered. The amount reported in [Schedule L] Part Iv ($200,000) is the cost of such services for the year." "The individuals listed were not a political party to the transactions. In that location is no sharing of the Institution'south revenue. The purchases of goods or services by the Institution were made in the ordinary class of the provider's business organization, at commercially available rates ordinarily charged to others..." [Notation: Every bit previously reported in the Heart's 2017 IRS Grade 990, Jose Baselga MD PhD was the Physician-in-Chief and Master Medical Officer of the Organization. As of at least 12/31/2017 he was also 100% owner of Memorial Medical Care PC.] Also according to the Memorial Sloan Kettering Cancer Center (the Center) 2019 taxation filing, the Center reports re: Loans to and/or from Interested Persons (IRS Course 990, Schedule L, Parts II & V, Attachment i): i. A loan from the organization to Lisa DeAngelis MD, Doctor-in-Principal, with a primary amount of $249,375 and a remainder due of $207,505 at 12/31/2019. The purpose of the loan is reported as "mortgage"; the loan is not in default, was not approved by lath or committee, and has a written agreement . 2. A loan from the organization to Simon Powell Md, Director, with a principal amount of $1,000,000 and a residue due of $300,000 at 12/31/2019. The purpose of the loan is reported as "housing"; the loan is not in default, was canonical past board or committee, and has a written agreement. |
| According to the Memorial Sloan Kettering Cancer Eye (the Institute) combined audit of December 31, 2019 (Note 11, Grant Awards): "The accompanying [audited] combined financial statements do not include amounts related to research grants (or portions thereof) that have been awarded to the Institute for which expenditures take not been incurred or cash has not been received. Such grant awards approximated $121.3 million and $113.5 one thousand thousand at December 31, 2019 and 2018, respectively." |
| Co-ordinate to the Memorial Sloan Kettering Cancer Middle (the Middle) 2019 taxation filing, the Center reports re: Bounty, Supplemental Information (IRS Course 990, Schedule J, Part Iii): Regarding severance payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 4a ): "Avice Meehan, SVP & Chief Advice Officeholder, [received severance pay] of $254,302. Terminated in May 2019." "Jose Baselga, Doc[,] PhD, former Physician in Primary & Chief Medical Officeholder [received severance pay] of $i,267,818. T erminated in September 2018. " [Notation: According to an article dated 12/22/2020 in The New York Times , "Memorial Sloan Kettering Cancer Centre gave Dr. José Baselga a payout later he resigned under fire in 2018 over his ties to wellness intendance companies." See the Related External Articles section, beneath: "Sloan Kettering Paid $i.v Million Severance to a Cancer Medico Forced Out Over Conflicts," and "Memorial Sloan Kettering Leaders Violated Disharmonize-of-Interest Rules, Report Finds."] "Incentive pay is provided to officers and key employees based on their achievement of pre-determined goals relating to quality of care, patient safety, operational efficiency and financial performance. The compensation committee of the lath authorizes all executive bonuses and incentive plans on an annual ground." (1) Craig B. Thompson Medico, President & CEO: $3,330,000, with reported full compensation of $5,734,609. In add-on, the Heart reports that 14 individuals received "Bonus & incentive compensation" payments in 2019 in amounts ranging from $571,560 to $243,030, and three individuals in amounts ranging from $88,540 to $50,000 (IRS Class 990, Schedule J, Part II). |
Related CharityWatch Manufactures
Related External Manufactures
Source: https://www.charitywatch.org/charities/memorial-sloan-kettering-cancer-center#:~:text=Program%20Percentage%3A%2098%25
0 Response to "what percent of donations to memorial sloan kettering cancer center is used for patients"
Post a Comment